Iveric Bio Inc (ISEE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -185,211 | -114,522 | -84,547 | -58,859 | 63,087 |
| Depreciation Amortization | -19 | 1,221 | 605 | 162 | 183 |
| Accounts payable and accrued liabilities | 9,987 | 64 | 7,163 | -241 | -1,682 |
| Other Working Capital | -4,717 | 3,497 | 9,522 | 1,092 | 3,128 |
| Other Operating Activity | 16,189 | 11,181 | 1,160 | 9,356 | -106,627 |
| Operating Cash Flow | $-163,771 | $-98,559 | $-66,097 | $-48,490 | $-41,911 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -236 | -361 | N/A | 150 | N/A |
| Purchase Of Investment | -231,040 | -142,821 | -143,810 | N/A | N/A |
| Sale Of Investment | 180,999 | 164,480 | N/A | N/A | N/A |
| Investing Cash Flow | $-50,277 | $21,298 | $-143,810 | $150 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 100,000 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 332,803 | 272,335 | 150,581 | 42,838 | 6,140 |
| Other Financing Activity | -3,898 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $428,905 | $272,335 | $150,581 | $42,838 | $6,140 |
| Beginning Cash Position | 261,447 | 66,373 | 125,699 | 131,201 | 166,972 |
| End Cash Position | 476,304 | 261,447 | 66,373 | 125,699 | 131,201 |
| Net Cash Flow | $214,857 | $195,074 | $-59,326 | $-5,502 | $-35,771 |
| Free Cash Flow | |||||
| Operating Cash Flow | -163,771 | -98,559 | -66,097 | -48,490 | -41,911 |
| Capital Expenditure | -736 | -361 | N/A | N/A | N/A |
| Free Cash Flow | -164,507 | -98,920 | -66,097 | -48,490 | -41,911 |